PsychiatricTimes Members: Login | Register
PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Blogs » Freedman

Psychiatric Times.
RESIDENT'S BLOG 

The Next Dr Waldenstrom?

By Jacob L. Freedman, MD | January 20, 2012
Dr Freedman is a resident in psychiatry at The Harvard Longwood Psychiatry Residency Training Program in Boston, Mass.

As I near the 1-year anniversary of my crowning as a World’s Expert, it seems like only yesterday that I was just an average citizen. You see, in April of 2011, I published a case report1 which effectively distinguished me as a leading authority on olanzapine(Drug information on olanzapine)-induced agranulocytosis in white male New England teenagers with a primary psychotic illness. It’s a limited field of expertise, with some 40 cases of this reaction documented across the literature.

But my Grandma was sure proud: “What a wonderful article,” she called to say, “I have no idea what it means or what’s happening but it was a wonderful article!” She then gave the phone to Uncle Jon, who was busy watching ESPN and didn’t have too much time to waste beyond asking me, “What the heck is Tangerine Osmosis?” My sister-in-law—always an optimist—promised she would skim the whole paper in between changing her newborn’s diapers.

My family’s true Osler, Aunt Kat, has written literally hundreds of peer-reviewed publications, book chapters, and editorials on global healthcare, utilization of resources, and other important topics. But I’m still the only physician in the family who’s been the lead author on a paper describing olanzapine-induced agranulocytosis in the patient population who can only see R-Rated movies with an adult. And Aunt Kat was frankly encouraging about the whole thing: “This is a great start to your career in influencing the care of really sick patients beyond the scope of your own clinical practice.”

Other people tried to be supportive. I got a pat on the back from my program director, which was nice. At least 1 of my co-residents had strongly considered reading the abstract—I got a text page saying, “Heard you got published . . . will check out the link after seeing 4 new consults and 6 follow-ups!”

I did not expect honors such as those bestowed upon Dr Jan Waldenstrom, the late Swedish physician who in 1944 described the lymphoplasmacytic lymphoma that bears his name. I don’t long for olanzapine-induced agranulocytosis in adolescents to be dubbed “The Freedman Reaction.” My sights are not set on an honorary membership in the Royal Society of Medicine alongside the specter of the departed Dr Waldenstrom.

Some deeper, more personal reward was missing.

And whatever that something was didn’t begin to dawn on me until my co-resident finally read the abstract—after seeing 19 patients on the psychosomatic medicine consult service—and sent me the following text: “Good job, buddy. How much time did you spend doing this though?” It was only then that I was able to do a proper accounting of all the hours that went into writing up the case report—15 hours of research, 7 hours on the first draft, 6 hours deliberating on the 2nd draft, 9 hours of rewrites and emails—it was a lot.

This wasn’t wasted time. On the contrary, I had learned to write up a case and had received excellent mentorship and supervision from my senior co-authors. I had made my family proud. But the endeavor highlighted the sacrifice required of clinicians who conduct research and publish papers.

Did I wish such a sacrifice to be my own?

More than once I’ve listened to Aunt Kat waxing rhapsodic on how she misses being a full-time clinician. To misquote her: “I often forget how beautiful it is to spend one’s days in the trenches of diagnosis, clinical management, and the patient-physician interactions—overflowing with humanity—that are the true magnificence of our profession.”

This sentiment resonates in me. I am at heart a clinician and a consummate clinician is what I aim to be. So, while it’s certainly a nice thing to be a World’s Expert, I’m becoming more and more convinced that a focus on clinical medicine might suit me best. Grandma will still be proud.

Acknowledgement: The author would like to thank Dr Ze’evi Sherman and all the people who read his case report either willingly or through friendly coercion.

Reference
1. Freedman JL, Ryan CA, Coffey BJ. Olanzapine-induced agranulocytosis in an adolescent male with psychosis. J Child Adolesc Psychopharmacol. 2011;21:185-189.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • The Moral Struggles of Practicing Psychiatrists
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Journey of the Traumatized Hero: Kerouac’s On the Road and Gandhi’s Railroad Ride
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
  • New Insight Into the Neurobiology of Depression
  • Cultural Psychiatry and the 'No-Chicken' Doctor
  • Benefits of CAM Therapies for Dementia
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter


 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy